跳至主要内容
临床试验/NCT06635408
NCT06635408已完成不适用

Cystatin c as a Predictive Biomarker of Acute Kidney Injury and Neurological Outcomes in Aneurysmal Subarachnoid Haemorrhage Patients

Alexandria University1 个研究点 分布在 1 个国家目标入组 52 人开始时间: 2023年10月30日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
52
试验地点
1
主要终点
Acute kidney injury

研究概览

简要总结

The goal of this observational study is to assess cystatin c as a predictive biomarker of early acute kidney injury in aneurysmal subarachnoid hemorrhage patients. The main question it aims to answer is:

  • Does cystatin c biomarker can predict early acute kidney injury in aneurysmal subarachnoid hemorrhage patients?

Participants will be grouped into Aki and Non-Aki groups based on RIFLE criteria and Cystatin c biomarker will be tested to answer the study question.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Patient admission to hospital within 48 hours of subarachnoid haemorrhage onset.
  • Subarachnoid haemorrhage caused by intracranial aneurysm rupture and is confirmed via computed tomography angiography (CTA).
  • Medical treatment, microsurgical clipping, or interventional endovascular treatment of aneurysm is performed within 48 hours of subarachnoid haemorrhage onset.

排除标准

  • Prior onset of subarachnoid haemorrhage or other neurological diseases such as ischemic stroke, hemorrhagic stroke, or severe head trauma.
  • Systemic diseases, such as chronic liver diseases, chronic lung diseases, chronic heart failure, thyroid diseases and cancer.
  • Renal impairment at time of admission (creatinine-based eGFR less than 60 ml/min per 1.73 m2 body surface area).
  • Patients who are hemodynamically unstable at time of admission.
  • Mortality within 10 days after admission (duration of study).

结局指标

主要结局

Acute kidney injury

时间窗: 6 days

stages "risk" and "injury" are considered early AKI

次要结局

  • Adverse neurological outcomes(10 days all except mortality within 28 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ahmed Ayman

principle investigator

Alexandria University

研究点 (1)

Loading locations...

相似试验

Cystatin c: a Biomarker of AKI in Aneurysmal... | 临床试验